Histopathologic changes induced by the microtubule-stabilizing agent Taxol in the rat hippocampus in vivo.
Mercado-Gómez
Octavio
O
Departamento de Biología Celular y Fisiología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, México.
Ferrera
Patricia
P
Arias
Clorinda
C
D000818:Animals; D000911:Antibodies, Monoclonal / Q000378:metabolism; D000972:Antineoplastic Agents, Phytogenic / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D006624:Hippocampus / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D007150:Immunohistochemistry / Q000379:methods; D007211:Indoles; D008297:Male; D046529:Microscopy, Electron, Transmission / Q000379:methods; D008869:Microtubule-Associated Proteins / Q000378:metabolism; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D017239:Paclitaxel / Q000633:toxicity*; D051381:Rats; D017208:Rats, Wistar; D013194:Staining and Labeling / Q000379:methods
D000911:Antibodies, Monoclonal; D000972:Antineoplastic Agents, Phytogenic; D005904:Glial Fibrillary Acidic Protein; D007211:Indoles; C489787:MAP2 protein, rat; D008869:Microtubule-Associated Proteins; C085349:PHF-1 monoclonal antibody; C085348:tau-1 monoclonal antibody; C007293:DAPI; D017239:Paclitaxel